Perspective Therapeutics, Inc. CATX
Set alert
1.02 USD -0.02 -1.92%
As of Nov 3, 10:15 AM ET
1.01 Day range 1.07
1.01 52-week range 6.16
- YTD
- -62.91%
- 1 year
- -60.77%
- Open
- 1.05
- Prev close
- 1.04
- Mkt cap
- 116.43M
- Vol
- 594.46K
- Avg vol
- 2.06M
- EPS
- -1.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.01
- High
- 1.07
- Forward P/E
- -2.91
- Beta
- 1.47
- Short ratio
- 4.69
- Inst. own
- 81.43%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.97
- 200-d avg
- 12.20
- 1y target
- 16.15
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 13, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 6, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
Held by funds
56 US ETFs and mutual funds hold CATX · largest positions
Ownership
Held by insiders 20.46%
Held by institutions 81.43%
Float held by institutions 102.37%
Institutions 174
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 8.14% | 5,504,822 | 17.29M | Sep 29, 2024 |
| Janus Henderson Group PLC | 7.10% | 4,799,352 | 15.07M | Sep 29, 2024 |
| Blackrock Inc. | 5.98% | 4,039,974 | 12.69M | Sep 29, 2024 |
| Avidity Partners Management, LP | 5.10% | 3,444,002 | 10.81M | Sep 29, 2024 |
| Commodore Capital Lp | 4.96% | 3,350,000 | 10.52M | Sep 29, 2024 |
| Vanguard Group Inc | 4.55% | 3,076,941 | 9.66M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.50% | 1,692,046 | 5.31M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.06% | 1,393,938 | 4.38M | Oct 30, 2024 |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.72% | 1,162,536 | 3.65M | Sep 29, 2024 |
| Fidelity Advisor Biotechnology Fund | 1.56% | 1,052,713 | 3.31M | Oct 30, 2024 |
| Janus Henderson Global Life Sciences Fund | 1.41% | 953,832 | 3.00M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.19% | 806,419 | 2.53M | Sep 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AUSTIN MARK JOHN | Chief Financial Officer | Conversion of Exercise of derivative security | Apr 22, 2024 | 84,030 |
| HENSON HEIDI | Director | Purchase | Dec 3, 2024 | 0 |
| HUNT JONATHAN ROBERT | Chief Financial Officer | Purchase | Nov 24, 2024 | 48,800 |
| LANTHEUS ALPHA THERAPY, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 5, 2024 | 0 |
| PUHLMANN MARKUS | Officer | Purchase | Jan 23, 2024 | 1,375,420 |
| SPOOR JOHAN M | Chief Executive Officer | Purchase | Dec 3, 2024 | 55,257 |